Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Zymfentra Pen (2 Pack)(Infliximab-Dyyb)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$1.5M

Medicare cost, 2024

Medicare drug plans spent $1.5 million on Zymfentra Pen (2 Pack) (infliximab-dyyb) in 2024, for 184 prescriptions and refills filled by 55 patients. At about $8,385 per prescription it is a high-cost drug.

Medicare cost, 2024

$1.5M

Prescriptions

184

$8,385.08 per claim

Patients

55

56 prescribers

Total spending, 2024

$1.5M

$28,051.91 per patient

Questions and answers

How much does Medicare spend on Zymfentra Pen (2 Pack)?

Medicare prescription drug plans paid $1.5M for Zymfentra Pen (2 Pack) in 2024, for 184 prescriptions and refills to 55 patients. The average cost per claim was $8,385.08.

Which state spends the most on Zymfentra Pen (2 Pack)?

Texas had the highest Medicare cost for Zymfentra Pen (2 Pack) in 2024: $286K for 27 claims, followed by Florida ($224K).

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Prescriber data by year

YearPrescribersClaimsPatientsCost
20245618455$1.5M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Celltrion USA,184$1.5M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube